AAV Gene Therapy Screening/Observational Protocol (ECLIPSE)

Clinical trial NCT04272554 · COMPLETED

Trial details

NCT number: NCT04272554
Sponsor: Spur Therapeutics
Status: COMPLETED
Study type: OBSERVATIONAL

Hemophilia B Blood Coagulation Disorders, Inherited Blood Coagulation Disorder Haematologic Disease

Start date: 2020-02-14
Primary completion: 2022-10-10
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.